Maintenance Therapies

 

Maintenance Therapies

When your cancer treatment ends, your doctor may want you to receive on-going medication or other treatment to help keep your cancer in remission. This is called maintenance therapy, because its goal is to maintain the effectiveness of the original treatment.

Maintenance therapy is used for various cancers, including lymphoma, breast cancer, lung cancer and leukemia, among others. The selection of a maintenance therapy depends upon cancer type, original treatment and other factors. Some maintenance therapies are well-established regimens; others are being tested in clinical trials.

Although you may feel some reassurance that you’re strengthening your prospects for remission by continuing anticancer medication or other maintenance therapy, it may also leave you feeling a bit like you’re in limbo. Your main treatment has ended, but with maintenance therapy, you may feel more like a patient than like someone who is moving forward.  

Take heart from the fact that maintenance therapy is part of your plan to sustain and strengthen your overall health. You may need to manage cancer long-term as part of that plan, but many people have to do the same with other health conditions, including asthma, heart disease, diabetes and high blood pressure.

Be sure to talk with your doctor about your maintenance therapy program so that you understand its schedule and goals. Just as with primary treatment, discuss questions about your medications or any side effects with your doctor as soon as possible. There are good solutions available for many side effects—solutions that will enable you to continue maintenance therapy and benefit from it.                                    

References

“Life After Treatment.” Caring4Cancer magazine. 2006.

Neumann F, Harmsen S, Martin S, et al. “Rituximab Long-term Maintenance Therapy After Autologous Stem Cell Transplantation in Patients with B-cell non-Hodgkin’s Lymphoma.” Annals of Hematology, 2006, Apr. 26, epub ahead of print.

“Glossary: Maintenance Therapy.” Living Beyond Breast Cancer.  http://www.lbbc.org/search.asp?q=maintenance+therapy&final=1&t=GLOSSARY. Accessed 5/16/06

Mattson K, Niiranen A, Ruotsalainen T, et al. “Interferon Maintenance Therapy for Small Cell Lung Cancer: Improvement in Long-Term Survival.” Journal of Interferon & Cytokine Research, 17(2):103-105, Feb. 1997.

Latest Urology News
Nighttime urination may lower bladder cancer risk

October 2, 2008 — NEW YORK (Reuters Health) - There may be an up side to having to "go" during the night. People who wake up at night to urinate are less likely to develop bladder cancer, an international research team has found.

Bladder problems keep women out of sports

September 29, 2008 — NEW YORK (Reuters Health) - A weak bladder keeps many women from taking part in recreational sports, according to an Italian study published in the British Journal of Sports Medicine.

Prostate cancer therapy linked to falls

September 24, 2008 — NEW YORK (Reuters Health) - Older men with prostate cancer who are on long-term hormone therapy often become weaker physically, leading to an increased risk of falls and injury, researchers report.

Select news items provided by Reuters Health